Methods: A protocol for RNA methylation differential analysis with MeRIP-Seq data and exomePeak R/Bioconductor package

Author links open overlay panelJiaMenga,  ZhiliangLua,  HuiLiub,  LinZhangb,  ShaowuZhangc, YidongChende, Manjeet K.Raoef,  YufeiHuanggd

Abstract

Despite the prevalent studies of DNA/Chromatin-related epigenetics, such as, histone modifications and DNA methylation, RNA epigenetics has not drawn deserved attention until a new affinity-based sequencing approach MeRIP-Seq was developed and applied to survey the global mRNA N6-methyladenosine (m6A) in mammalian cells. As a marriage of ChIP-Seq and RNA-Seq, MeRIP-Seq has the potential to study the transcriptome-wide distribution of various post-transcriptional RNA modifications.

We have previously developed an R/Bioconductor package ‘exomePeak’ for detecting RNA methylation sites under a specific experimental condition or identifying the differential RNA methylation sites in a case-control study from MeRIP-Seq data. Compared with other relatively well-studied data types such as ChIP-Seq and RNA-Seq, the study of MeRIP-Seq data is still at a very early stage, and existing protocols are not optimized for dealing with the intrinsic characteristic of MeRIP-Seq data. We therein provide here a detailed and easy-to-use protocol of using the exomePeak R/Bioconductor package along with other software programs for analysis of MeRIP-Seq data, which covers raw reads alignment, RNA methylation site detection, motif discovery, differential RNA methylation analysis, and functional analysis. Particularly, the rationales behind each processing step as well as the specific method used, the best practice, and possible alternative strategies are briefly discussed.

The exomePeak R/Bioconductor package is freely available from Bioconductorhttp://www.bioconductor.org/packages/release/bioc/html/exomePeak.html

Keywords

  • RNA methylation
  • MeRIP-Seq
  • exomePeak
  • Differential RNA methylation
  • N6-methyladenosine (m6A)

Learn More Button

Article Categories: All News, Research Paper

Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to understanding its causes, and accelerate the translation of knowledge into novel therapies. Greehey CCRI strives to have a national and global impact on childhood cancer by discovering, developing, and disseminating new scientific knowledge. Our mission consists of three key areas — research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.